Celltrion records highest 63% in gross-profit ratio in 1st quarter
Among listed pharmaceutical companies, Celltrion recorded the highest, 63%, in the gross-profit ratio, and Hwail Pharm, active pharmaceutical ingredient company, recorded the lowest, 14%.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of KOSPI and KOSDAQ listed pharmaceutical...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
